372896001: Carbinoxamine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Histamine receptor antagonist\Ethanolamine derivative antihistamine\Carbinoxamine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Carbinoxamine (substance)

\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Ethanolamine and/or ethanolamine derivative (substance)\Ethanolamine derivative antihistamine\Carbinoxamine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1198191019 Carbinoxamine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1211414019 Carbinoxamine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4494441000005114 Carbinoxamin da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Carbinoxamine (substance)	Is a	Sederende antihistamin	false	Inferred relationship	Some
Carbinoxamine (substance)	Is a	Ethanolamine derivative antihistamine	true	Inferred relationship	Some
Carbinoxamine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Histamine receptor antagonist (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Carbinoxamine maleate	Is a	False	Carbinoxamine (substance)	Inferred relationship	Some
Carbinoxamine measurement	Component	True	Carbinoxamine (substance)	Inferred relationship	Some	1
carbinoxaminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 15 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/1 ml/4 mg/1 ml/25 mg/1 ml væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat 2 mg/1 ml + dextromethorphanhydrobromid 4 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat + pseudoephedrinhydrochlorid 4 mg/5 ml/60 mg/5 ml væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat 2 mg/1 ml + pseudoephedrinhydrochlorid 15 mg/1 ml væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat + pseudoephedrinhydrochlorid 2 mg/1 ml/25 mg/1 ml væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat 2 mg/5 ml + pseudoephedrinhydrochlorid 30 mg/5 ml væske	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat + pseudoephedrinhydrochlorid 8 mg/120 mg tablet med modificeret udløsning	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml/12,5 mg/5 ml/60 mg/5 ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 1 mg/1 ml/4 mg/1 ml/15 mg/1 ml dråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat + pseudoephedrinhydrochlorid 1 mg/1 ml/15 mg/1 ml dråber	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
Product containing carbinoxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
carbinoxaminmaleat 4 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some
carbinoxaminmaleat 4 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Carbinoxamine (substance)	Inferred relationship	Some	1
carbinoxaminmaleat 4 mg tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Carbinoxamine (substance)	Inferred relationship	Some	1
Product containing carbinoxamine and dextromethorphan and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Carbinoxamine maleate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Carbinoxamine (substance)	Inferred relationship	Some
Product containing carbinoxamine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
carbinoxaminmaleat 4 mg tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Carbinoxamine (substance)	Inferred relationship	Some	1
Product containing carbinoxamine and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Product containing carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Product containing only carbinoxamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Carbinoxamine and dextromethorphan and pseudoephedrine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Carbinoxamine and pseudoephedrine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Carbinoxamine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Carbinoxamine and dextromethorphan and pseudoephedrine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1
Product containing carbinoxamine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Carbinoxamine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1198191019	Carbinoxamine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1211414019	Carbinoxamine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4494441000005114	Carbinoxamin	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)